Skip to main content
Top
Published in: Advances in Gerontology 1/2019

01-01-2019 | Erectile Dysfunction

Ontogenetic Characteristics of Patients with Erectile Dysfunction with Different Types of Aging

Authors: V. I. Odin, V. I. Didenko

Published in: Advances in Gerontology | Issue 1/2019

Login to get access

Abstract

Age-related erectile dysfunction (ED) can form during ontogenesis in accordance with various mechanisms of the pathogenesis of aging in conjunction with a particular cluster of diseases. The goal of this work is to study the ontogenetic features of ED patients in late ontogeny who vary by types of aging. The study comprised 65 men over 45 years old with an explicit form of ED. The first group consisted of patients with general somatic diseases (GSDs) following the accumulative model of aging, and the second group included patients with age-associated diseases (AADs) that arose primarily from the ontogenetic model of aging. Both types of age-related ED are closely connected with ontogenetic events, especially with the onset of obesity and the loss of morning erections (which precede the onset of ED), on average over a decade of life. ED with AADs is the most clinically and pathogenetically compromised. Thus, it is characterized by an earlier age of ED onset, a dysmetabolic pattern, a low geroprotective pattern, a poor quality of primary health, pronounced instability of the gonadostat, a weak sexual constitution, decreased sensitivity of the hypothalamic-pituitary complex to feedback signals, and a large proliferative pattern. ED associated with GSDs had a later age of ED onset, developed much later from the onset of obesity, and had a lower level of testicular volume with a more conserved incretory function but a higher index of IPSS. Therefore, the separation of two ED variants associated with different types of aging in conjunction with the use of ontogenetic analysis allowed the identification of significant differences in clinical and pathogenic forms, which is important for the development of ideas on the diagnosis and treatment of age-related ED.
Literature
1.
go back to reference Vasil’chenko, G.S., Agarkova, T.E., Agarkov, S.T., et al., Seksopatologiya: Spravochnik (Sexopathology: Handbook), Moscow: Meditsina, 1990. Vasil’chenko, G.S., Agarkova, T.E., Agarkov, S.T., et al., Seksopatologiya: Spravochnik (Sexopathology: Handbook), Moscow: Meditsina, 1990.
2.
go back to reference Dedov, I.I., Mel’nichenko, G.A., Rozhivanov, R.V., and Kurbatov, D.G., Recommendations for diagnostics and treatment of testosterone deficiency (hypogonadism) in men, Probl. Endokrinol., 2015, vol. 61, no. 5, pp. 60–71.CrossRef Dedov, I.I., Mel’nichenko, G.A., Rozhivanov, R.V., and Kurbatov, D.G., Recommendations for diagnostics and treatment of testosterone deficiency (hypogonadism) in men, Probl. Endokrinol., 2015, vol. 61, no. 5, pp. 60–71.CrossRef
3.
go back to reference Russian Society of Cardiology: National Guidelines on Metabolic Syndrome, Kardiovask. Ter. Profil., 2007, vol. 6, suppl. 6, pp. 1–26. Russian Society of Cardiology: National Guidelines on Metabolic Syndrome, Kardiovask. Ter. Profil., 2007, vol. 6, suppl. 6, pp. 1–26.
4.
go back to reference Dil’man, V.M., Chetyre modeli meditsiny (Four Models of Medicine), Leningrad: Meditsina, 1987. Dil’man, V.M., Chetyre modeli meditsiny (Four Models of Medicine), Leningrad: Meditsina, 1987.
5.
go back to reference Kad’yan, A.A., Naselenie Sankt-Peterburgskikh gradskikh bogadelen (materially k izucheniyu starosti po issledovaniyu, proizvedennomu pod rukovodstvom S.P. Botkina v 1889 g.) (Population of St. Petersburg City Almshouses: The Data for Study Elderly according to the Research of S.P. Botkin in 1889), St. Petersburg, 1890. Kad’yan, A.A., Naselenie Sankt-Peterburgskikh gradskikh bogadelen (materially k izucheniyu starosti po issledovaniyu, proizvedennomu pod rukovodstvom S.P. Botkina v 1889 g.) (Population of St. Petersburg City Almshouses: The Data for Study Elderly according to the Research of S.P. Botkin in 1889), St. Petersburg, 1890.
6.
go back to reference Odin, V.I., Gamayunova, V.B., and Bershtein, L.M., Content of dehydroepiandrosterone, testosterone and cortisol in newly diagnosed type 2 diabetes, Probl. Endokrinol., 1999, vol. 45, no. 5, pp. 18–21. Odin, V.I., Gamayunova, V.B., and Bershtein, L.M., Content of dehydroepiandrosterone, testosterone and cortisol in newly diagnosed type 2 diabetes, Probl. Endokrinol., 1999, vol. 45, no. 5, pp. 18–21.
7.
go back to reference Odin, V.I., Gerontology crisis: question on primary health in the 20th century, Adv. Gerontol., 2011, vol. 1, no. 4, pp. 273–283.CrossRef Odin, V.I., Gerontology crisis: question on primary health in the 20th century, Adv. Gerontol., 2011, vol. 1, no. 4, pp. 273–283.CrossRef
8.
go back to reference Odin, V.I., Didenko, V.I., Kochanova, E.A., et al., Types of aging and vegetative status of patients with erectile dysfunction in late ontogenesis, Vestn. Ross. Voen.-Med. Akad., 2017, vol. 3, no. 59, pp. 105–108. Odin, V.I., Didenko, V.I., Kochanova, E.A., et al., Types of aging and vegetative status of patients with erectile dysfunction in late ontogenesis, Vestn. Ross. Voen.-Med. Akad., 2017, vol. 3, no. 59, pp. 105–108.
9.
go back to reference Odin, V.I., Dvorovkin, A.E., Inamova, O.V., et al., Ontogenetic forms of rheumatoid arthritis associated with autoimmune thyroiditis, Usp. Gerontol., 2018, vol. 31, no. 1, pp. 126–131. Odin, V.I., Dvorovkin, A.E., Inamova, O.V., et al., Ontogenetic forms of rheumatoid arthritis associated with autoimmune thyroiditis, Usp. Gerontol., 2018, vol. 31, no. 1, pp. 126–131.
10.
go back to reference Brand, J.S., van der Tweel, I., Grobbee, D.E., et al., Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systematic review and meta-analysis of observational studies, Int. J. Epidemiol., 2011, vol. 40, no. 1, pp. 189–207.CrossRefPubMed Brand, J.S., van der Tweel, I., Grobbee, D.E., et al., Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systematic review and meta-analysis of observational studies, Int. J. Epidemiol., 2011, vol. 40, no. 1, pp. 189–207.CrossRefPubMed
11.
go back to reference Corona, G., Vignozzi, L., Sforza, A., et al., Obesity and late-onset hypogonadism, Mol. Cell. Endocrinol., 2015, vol. 418, pp. 120–133.CrossRefPubMed Corona, G., Vignozzi, L., Sforza, A., et al., Obesity and late-onset hypogonadism, Mol. Cell. Endocrinol., 2015, vol. 418, pp. 120–133.CrossRefPubMed
12.
go back to reference Dilman, V.M., Development, Aging, and Disease. A New Rationale for and Intervention Strategy, Chur: Harwood Academic, 1994. Dilman, V.M., Development, Aging, and Disease. A New Rationale for and Intervention Strategy, Chur: Harwood Academic, 1994.
13.
go back to reference Handelsman, D.J. and Staraj, S., Testicular size: the effects of aging, malnutrition, and illness, J. Androl., 1985, vol. 6, no. 3, pp. 144–151.CrossRefPubMed Handelsman, D.J. and Staraj, S., Testicular size: the effects of aging, malnutrition, and illness, J. Androl., 1985, vol. 6, no. 3, pp. 144–151.CrossRefPubMed
14.
go back to reference Heinemann, L.A.J., et al., The Aging Males’ Symptoms (AMS) scale: update and compilation of international versions, Health Qual. Life Outcomes, 2003, vol. 1, pp. 15–21.CrossRefPubMedPubMedCentral Heinemann, L.A.J., et al., The Aging Males’ Symptoms (AMS) scale: update and compilation of international versions, Health Qual. Life Outcomes, 2003, vol. 1, pp. 15–21.CrossRefPubMedPubMedCentral
15.
go back to reference Jockenhovet, F., Male Hypogonadism, Bremen: Uni-Med, 2004. Jockenhovet, F., Male Hypogonadism, Bremen: Uni-Med, 2004.
16.
go back to reference Korenchevsky, V.G., Physiological and Pathological Ageing, Basel: S. Karger Verlag, 1961. Korenchevsky, V.G., Physiological and Pathological Ageing, Basel: S. Karger Verlag, 1961.
17.
go back to reference NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence, JAMA, J. Am. Med. Assoc., 1993, vol. 270, no. 1, pp. 83–90. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence, JAMA, J. Am. Med. Assoc., 1993, vol. 270, no. 1, pp. 83–90.
18.
go back to reference Quilter, M., Hodges, L., von Hurst, P., et al., Male sexual function in New Zealand: a population-based cross-sectional survey of the prevalence of erectile dysfunction in men aged 40–70 years, J. Sex. Med., 2017, vol. 14, no. 7, pp. 928–936.CrossRefPubMed Quilter, M., Hodges, L., von Hurst, P., et al., Male sexual function in New Zealand: a population-based cross-sectional survey of the prevalence of erectile dysfunction in men aged 40–70 years, J. Sex. Med., 2017, vol. 14, no. 7, pp. 928–936.CrossRefPubMed
19.
go back to reference Rosen, R.C., Riley, A., Wagner, G., et al., The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction, Urology, 1997, vol. 49, no. 6, pp. 822–830.CrossRefPubMed Rosen, R.C., Riley, A., Wagner, G., et al., The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction, Urology, 1997, vol. 49, no. 6, pp. 822–830.CrossRefPubMed
20.
go back to reference Tewari, R., Rajender, S., Natu, S.M., et al., Diet, obesity, and prostate health: are we missing the link?, J. Androl., 2012, vol. 33, no. 5, pp. 763–776.CrossRefPubMed Tewari, R., Rajender, S., Natu, S.M., et al., Diet, obesity, and prostate health: are we missing the link?, J. Androl., 2012, vol. 33, no. 5, pp. 763–776.CrossRefPubMed
Metadata
Title
Ontogenetic Characteristics of Patients with Erectile Dysfunction with Different Types of Aging
Authors
V. I. Odin
V. I. Didenko
Publication date
01-01-2019
Publisher
Pleiades Publishing
Published in
Advances in Gerontology / Issue 1/2019
Print ISSN: 2079-0570
Electronic ISSN: 2079-0589
DOI
https://doi.org/10.1134/S2079057019010119

Other articles of this Issue 1/2019

Advances in Gerontology 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.